• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results

  • in Cardiovascular
  • — 5 Sep, 2007
Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results
AudioMedica News
Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results
Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-344"/>
Stefano Ghio
Stefano Ghio
Cecilia Linde
Cecilia Linde

REFERENCE: Hotline III, 3222 page 315, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
STEFANO GHIO, San Matteo University Hospital, Italy
COMMENT: CECILIA LINDE, Karolinska University Hospital, Stockholm

The standard echocardiographic criteria for selecting patients to receive cardiac resynchronisation are not adequate according to Stefano Ghio. During the ESC Congress in Vienna he presented results from the PROSPECT trial and afterwards he talked with Sarah Maxwell. Cecilia Linde gave Nicola Solomon her comments on the findings.

[audio:https://www.audiomedica.com/podcasting/cardio/070904_ghio_linde.mp3]

You may also like...

  • 50% of Women are Over-treated in Acute Coronary Syndromes 50% of Women are Over-treated in Acute Coronary Syndromes 17 Nov, 2005
  • Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension? Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension? 29 Jun, 2009
  • Heart Attacks Drop After Smoking Ban in Ireland Heart Attacks Drop After Smoking Ban in Ireland 5 Sep, 2007
  • Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions 3 Sep, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Patients with High Restenosis Risk Benefit More from Drug Eluting Stents
  • Next story Drug Eluting Stents: Higher Late Mortality in STEMI Patients Than Bare Metal: GRACE Registry Findings
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
    • Reassurance on Ductal Carcinoma in Situ (DCIS)…
    • Head and Neck Cancer Therapy De-Escalation: A…
  • Home
  • Cardiovascular
  • Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results

© COPYRIGHT 2020 AUDIOMEDICA.COM.